Last reviewed · How we verify
Bupivacaine with Epinephrine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bupivacaine with Epinephrine (Bupivacaine with Epinephrine) — University of North Carolina, Chapel Hill.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bupivacaine with Epinephrine TARGET | Bupivacaine with Epinephrine | University of North Carolina, Chapel Hill | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bupivacaine with Epinephrine CI watch — RSS
- Bupivacaine with Epinephrine CI watch — Atom
- Bupivacaine with Epinephrine CI watch — JSON
- Bupivacaine with Epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). Bupivacaine with Epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-with-epinephrine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab